4Roman LD, Fedorov KA, Krasnozhon DA. Comparative clinical evaluation of the effectiveness of modified radical mastectomy and organ-preserving therapy in localized breast cancer (pT1-2N0M0)[J]. Bonpoci, ,2004,50(1) :184-188.
5Chang AP, Sacchini V. Nipple-sparing mastectomy :where are we now?[J]. Surg Oncol, 2008,17 (4) : 261-266.
6Fisher B, Anderson S,Bryant J, et al. Twenty-year follow-up of a randomized trim comparing total mastectomy, lumpeetomy, and lumpectomy plus irra- diation for the treatment of invasive breast cancer[J]. N Engl J Med ,2002, 347(16) : 1233-1241.
7NIH consensus conference. Treatment of early-stage breast cancer[J]. JAMA, 1991,265( 1 ) :391-395.
8Rouzier R ,Mathieu MC ,Sideris L,et al. Breast-conserving surgery after neoadjuvant anthracycline-based chemotherapy for large breast tumors[J]. Cancer,2004,101 (5) :918-925.
9Bear HD ,Anderson S,Smith RE ,et al. Sequential preoperative or post- operative docetaxel added to preoperative doxorubicin plus cyclophospha- mide for operable breast cancer:National Surgical Adjuvant Breast and Bowel Project Protocol B-27 [J]. J Clin Oncol, 2006,24 ( 13 ) : 2019-2027.
10Neuschatz AC, DiPetrillo T, Safaii H, et al. Long-term follow-up of a pro- spective policy of margin-directed radiation dose escalation in breast-con- serving therapy[J]. Cancer, 2003,97 ( 1 ) : 30-39.
